Meagan-Helen Henderson Berg (M H Henderson Berg, M-H Henderson Berg)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Tyrosine Kinase

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Top Venues

Journal of cutaneous medicine and surgery

Journal for immunotherapy of cancer

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Meagan-Helen Henderson Berg, Gizelle Popradi, David Roberge, Tina Petrogiannis-Haliotis, Kevin Pehr
Psychological Distress and Treatment Outcome in Patients With Early-Stage Mycosis Fungoides. Journal of cutaneous medicine and surgery 28 (1) (2024)
Meagan-Helen Henderson Berg, Gizelle Popradi, David Roberge, Tina Petrogiannis-Haliotis, Kevin Pehr
Psychological Distress and Treatment Outcome in Patients With Early-Stage Mycosis Fungoides. Journal of cutaneous medicine and surgery 28 (1) (2024)
Meagan-Helen Henderson Berg, Gizelle Popradi, David Roberge, Tina Petrogiannis-Haliotis, Kevin Pehr
Psychological Distress and Treatment Outcome in Patients With Early-Stage Mycosis Fungoides. Journal of cutaneous medicine and surgery (2024)
Meagan-Helen Henderson Berg, Gizelle Popradi, David Roberge, Tina Petrogiannis-Haliotis, Kevin Pehr
Psychological Distress and Treatment Outcome in Patients With Early-Stage Mycosis Fungoides. Journal of cutaneous medicine and surgery 28 (1) (2024)
Meagan-Helen Henderson Berg, Sonia Victoria Del Rincón, Wilson H Miller
Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibition. Journal for immunotherapy of cancer 10 (1) (2022)
Khashayar Esfahani, Meagan-Helen Henderson Berg, Hanieh Zargham, Robin Billick, Kevin Pehr, Margaret Redpath, Osama Roshdy, Wilson H Miller
Narrowband ultraviolet B therapy for refractory immune-related lichenoid dermatitis on PD-1 therapy: a case report. Journal for immunotherapy of cancer 9 (3) (2021)
Meagan-Helen Henderson Berg, K Davison, G Popradi
Real-world effectiveness of brentuximab vedotin in the treatment of CD30-positive cutaneous T-cell lymphoma: a single-centre retrospective review. The British journal of dermatology (2021)
A Chirico, Meagan-Helen Henderson Berg, David Roberge, Kevin Pehr
Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphoma. The British journal of dermatology 184 (2) (2020)